Dark

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ

Market Open

Feb 5, 2026 11:12:13 AM EST

9.65USD+12.471%(+1.07)10,334,589

9.30Bid 9.38Ask 0.08Spread

Pre-market

Feb 5, 2026 9:29:41 AM EST

11.91USD+38.811%(+3.33)2,989,198

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

8.88M

Industry

Biotechnology

Last Split

May 15, 20251for28reverse

RNAZ Stats

Avg. Vol. 10 Day

21,030

Avg. Vol. 30 Day

104,108

Employees

Market Cap

8,876,250

Shares Out.

916,968

On/Off Exchange

64%/36%

6 Month Beta

0.61

1 Year Beta

0.85

2 Year Beta

1.00

3 Year Beta

-0.17

52 Week Low

6.08

52 Week High

399.00

SMA50

8.67

SMA200

9.75

1 Week

-7.61%

1 Month

+32.42%

3 Month

+1.15%

6 Month

-15.83%

1 Year

-96.13%

2 Year

-98.18%

5 Year

-100.00%

Profile

transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.

RNAZ Stock Summary

TransCode Therapeutics, Inc. Common Stock (NASDAQ:RNAZ) stock price today is $9.65, and today's volume is 10,334,589. RNAZ is up 12.471% today. The 30 day average volume is 104,108. RNAZ market cap is 8.88M with 916,968 shares outstanding.

.dark-mode .q5qCPv{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .q5qCPv{ color: #333333; background-color: white; border: 2px solid #333333; }RNAZTransCode Therapeutics, Inc. Common Stockstock NASDAQ

RNAZ Stock Summary

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ